Hematopoietic Stem Cell TransplantationTransplantation, AutologousPeripheral Blood Stem Cell TransplantationTransplantation ConditioningTransplantation, HomologousMelphalanHematologic NeoplasmsHematopoietic Stem Cell MobilizationCombined Modality TherapyHematopoietic Stem CellsMultiple MyelomaStem Cell TransplantationTreatment OutcomeAntigens, CD34Graft vs Host DiseaseLymphoma, Non-HodgkinGranulocyte Colony-Stimulating FactorMyeloablative AgonistsCyclophosphamideLeukapheresisAntineoplastic Combined Chemotherapy ProtocolsGraft SurvivalDisease-Free SurvivalBlood Component RemovalBone Marrow TransplantationBusulfanRetrospective StudiesRemission InductionRecurrenceStem CellsSalvage TherapySurvival RateWhole-Body IrradiationEtoposideThiotepaTransplantation ChimeraAntineoplastic Agents, AlkylatingHematopoiesisCord Blood Stem Cell TransplantationTissue DonorsCarmustineSurvival AnalysisImmunosuppressive AgentsCytophagocytosisHistocompatibilityCytarabineVincristineHistocompatibility TestingIfosfamideHodgkin DiseaseAmyloidosisTime FactorsNeoplasmsLeukemiaGraft vs Leukemia EffectLeukemia, Myeloid, AcuteVidarabineInfectionAntineoplastic AgentsTransplantation, IsogeneicLiver TransplantationLymphoma, T-CellFollow-Up StudiesPlatelet CountDoxorubicinCytomegalovirus InfectionsMyelodysplastic SyndromesPrognosisPrednisoneHematologic DiseasesBlood Cell CountPOEMS SyndromeHLA AntigensMesenchymal Stem Cell TransplantationDexamethasoneProspective StudiesLymphomaAnemia, AplasticFatal OutcomeBlood CellsBone Marrow PurgingCarboplatinBone MarrowLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRecombinant ProteinsCell TransplantationLymphocyte DepletionT-LymphocytesFlow CytometryPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow CellsFeasibility StudiesCell DifferentiationChimerismImmunophenotypingSiblingsBlood Transfusion, AutologousTransplantation ImmunologyEmbryonic Stem CellsOpportunistic Infections